Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report)’s stock price hit a new 52-week low during trading on Wednesday . The company traded as low as $20.18 and last traded at $20.18, with a volume of 130 shares changing hands. The stock had previously closed at $20.5920.
Hikma Pharmaceuticals Trading Down 2.0%
The stock’s fifty day moving average price is $22.77 and its two-hundred day moving average price is $25.30. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.24 and a quick ratio of 0.72.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- 5 Top Rated Dividend Stocks to Consider
- Why GRAIL Stock Could Be Biotech’s Next Big Breakout
- Transportation Stocks Investing
- Why Ford’s Deal With Amazon Is Bigger Than You Think
- The How And Why of Investing in Oil Stocks
- Buyer Beware: Carvana Is Driving an Auto Lending Crisis
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
